PD
CYTK icon

Point72 (DIFC)’s Cytokinetics CYTK Stock Holding History

Point72 (DIFC)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$162K Buy
+2,942
New +$121K 0.01% 490
2025
Q2 		– Sell
-11,515
Closed -$463K – 1671
2025
Q1 		$463K Sell
11,515
-3,443
-23% -$158K 0.02% 666
2024
Q4 		$704K Buy
+14,958
New +$777K 0.03% 554

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Point72 (DIFC)'s CYTK Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Cytokinetics (CYTK) in Q3 2025: 2,942 shares worth $162K. The stake represents 0.01% of the portfolio and ranks #490 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in CYTK as recently as Q1 2025.

Point72 (DIFC) first reported a position in CYTK in Q4 2024 and has held it in 3 quarters since. The position peaked at $704K in Q4 2024. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

  • Point72 (DIFC) held 2,942 shares of Cytokinetics worth $162K as of Q3 2025.
  • Cytokinetics was a new Point72 (DIFC) position in Q3 2025.
  • Cytokinetics made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #490 holding.
  • Point72 (DIFC) first reported a position in Cytokinetics in Q4 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Cytokinetics position peaked at $704K in Q4 2024.
  • 380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.